Earlier this month, the FDA approved two other treatments for multiple myeloma, including another kind of monoclonal antibody drug (the same class of drug that elotuzumab is in). (businessinsider.com)
In this 42 - patient, ovarian cancer study, DPX - Survivac is being combined with Keytruda (pembrolizumab), Merck's anti-PD monoclonal antibody drug. (thelifesciencesreport.com)
Denosumab, a fully human monoclonal antibody drug, binds specifically to RANK - ligand (RANKL) and inhibits osteoclast - induced bone resorption by preventing the binding of RANKL to RANK. (sciencedaily.com)